DEPDC1 and plasma cell myeloma: Of note, DEPDC1 was found to be highly expressed in bladder cancer [36], hepatocellular carcinoma [37], and multiple myeloma [38], acting as a novel diagnostic marker or prognostic predictor, indicating that overexpression of DEPDC1 might play a role in the development and progression of cancers.